GR
Grasim
Q3 FY24 · Diversified
Grasim's Q3 FY24 consolidated revenue grew 12% YoY to INR 31,965 crore, with EBITDA up 34% to INR 5,150 crore, driven by volume growth in VSF (34%) and caustic soda (5%), though realizations remained weak due to global oversupply. Standalone revenue was INR 6,400 crore (+3% YoY). The paints business (Birla Opus) is on track for launch in Q4 FY24 with trial production at three plants, targeting pan-India distribution by FY25 end. B2B e-commerce Birla Pivot achieved INR 120 crore monthly revenue run-rate. VSF margins are expected to bottom out, while chemicals remain stable to gently improving. Risks include continued pressure from cheap Chinese imports and Red Sea disruptions impacting export trade.
- Guidance read
- Paints launch in Q4 FY24 with pan-India distribution by FY25 end: Birla Opus will launch in Q4 FY24 starting with North and South India, targeting national distribution by end of FY25. Net debt-to-EBITDA to reach 3-3.5x post paints capex: Management guided net debt-to-EBITDA of 3-3.5x after completing paints capex and rights issue proceeds. Capex guidance of INR 5,900 crore for FY24: Management reiterated plant capex guidance of about INR 5,900 crore for FY24, with 76% allocated to paints.
- Risk read
- Key risks include Cheap Chinese imports impacting VSF realizations — VSF realizations declined 2% QoQ due to cheaper imports from China, pressuring margins.; Red Sea disruptions affecting global trade — Red Sea disruptions are impacting 12-15% of world trade, including 30% of container traffic, creating uncertainty for export markets.; Chlorine pricing remains negative due to agrochem slowdown — Chlorine realizations worsened by INR 2,000 sequentially to negative INR 4,000, driven by slow agrochem demand.; Paints business losses increasing ahead of launch — Paints EBITDA losses increased QoQ as uncapitalized expenses rise; profitability timeline remains uncertain..
- Promise ledger
- Of 2 tracked promises, management 0 met, 0 close, 2 missed.
BA
Bajajfinsv
Q3 FY24 · Diversified
Bajaj Finserv reported a strong Q3 FY24 with consolidated total income up 34% to INR 29,038 crore and PAT up 21% to INR 2,158 crore. Growth was driven by robust performance across subsidiaries: Bajaj Finance (AUM +35%, PAT +22%), Bajaj Allianz General Insurance (GDPI +18.7% despite Nat Cat impact), and Bajaj Allianz Life Insurance (IRNB +24%, NBV +19%). The company announced the acquisition of Vidal Healthcare for INR 325 crore to strengthen its healthcare payment ecosystem. Management expressed confidence in sustained growth, citing favorable macro conditions and strategic investments. Key risks include potential regulatory changes on life insurance surrender norms and competitive pressure in motor insurance.
- Guidance read
- Bajaj Allianz Life to maintain market-leading growth: Management expects continued strong growth in IRNB, with focus on product mix and channel diversification. Bajaj Allianz General to sustain above-industry growth: The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion. Bajaj Finserv Health to scale via Vidal acquisition: The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum. Bajaj Finance to resume digital card issuance soon: Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
- Risk read
- Key risks include Regulatory risk on life insurance surrender norms — Proposed IRDAI changes to surrender values could impact product profitability and persistency.; Intense competition in motor insurance — Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.; Dependence on bank insurance partners — Banks may prioritize deposits over third-party products, pressuring bancassurance growth.; Natural catastrophe claims impact — Frequent Nat Cat events increased combined ratio to 102.9% in Q3; core profitability remains strong..
- Promise ledger
- Of 3 tracked promises, management 0 met, 0 close, 3 missed.